Journal
INFECTION AND IMMUNITY
Volume 89, Issue 2, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/IAI.00677-20
Keywords
acid ceramidase; ceramide; sphingosine; Pseudomonas aeruginosa; cystic fibrosis; pneumonia
Categories
Ask authors/readers for more resources
Genetic overexpression of acid ceramidase in cystic fibrosis mice increases immunity and protects against pulmonary infections with P. aeruginosa. Sphingosine has been shown to effectively kill pathogenic bacteria. Normalizing sphingosine levels in airway epithelial cells can prevent infections in cystic fibrosis patients.
Previous studies have shown that sphingosine kills a variety of pathogenic bacteria, including Pseudomonas aeruginosa and Staphylococcus aureus. Sphingosine concentrations are decreased in airway epithelial cells of cystic fibrosis (CF) mice, and this defect has been linked to the infection susceptibility of these mice. Here, we tested whether the genetic overexpression of acid ceramidase rescues cystic fibrosis mice from pulmonary infections with P. aeruginosa. We demonstrate that the transgenic overexpression of acid ceramidase in CF mice corresponds to the overexpression of acid ceramidase in bronchial and tracheal epithelial cells and normalizes ceramide and sphingosine levels in bronchial and tracheal epithelial cells. In addition, the expression of beta 1-integrin, which is ectopically expressed on the luminal surface of airway epithelial cells in cystic fibrosis mice, an alteration that is very important for mediating pulmonary P. aeruginosa infections in cystic fibrosis, is normalized in cystic fibrosis airways upon the overexpression of acid ceramidase. Most importantly, the overexpression of acid ceramidase protects cystic fibrosis mice from pulmonary P. aeruginosa infections. Infection of CF mice or CF mice that inhaled sphingosine with P. aeruginosa or a P. aeruginosa mutant that is resistant to sphingosine indicates that sphingosine and not a metabolite kills P. aeruginosa upon pulmonary infection. These studies further support the use of acid ceramidase and its metabolite sphingosine as potential treatments of cystic fibrosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available